Immune rejection after pancreatic islet cell transplantation: In vivo dual contrast-enhanced MR imaging in a mouse model

Radiology

Volumn 266, Issue 3, 2013, Pages 822-830

  Wang, Ping ^a   Schuetz, Christian ^a   Ross, Alana ^a   Dai, Guangping ^a   Markmann, James F ^a   Moore, Anna ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; COPOLYMER; FLUORESCEIN ISOTHIOCYANATE; GADOLINIUM; PENTETIC ACID; PHOSPHATE BUFFERED SALINE; PROTECTED GRAFT COPOLYMER GADOLINIUM DIETHYLENETRIAMINEPENTAACETIC PENTAACETIC ACID FLUORESCEIN ISOTHIOCYANATE; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTRAST MEDIUM EXTRAVASATION; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; CELLS, CULTURED; CONTRAST MEDIA; DEXTRANS; DIABETES MELLITUS; FLUORESCEIN-5-ISOTHIOCYANATE; GADOLINIUM DTPA; GRAFT REJECTION; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MICE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84874333152     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12121129     Document Type: Article

References (35)

1. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006;355(13): 1318-1330.
2. Lacotte S, Berney T, Shapiro AJ, Toso C. Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events. Expert Opin Biol Ther 2011;11(1): 55-66.
3. Diab R, Iwata T, Corbascio M, et al. Effect of triple costimulation blockade on islet allograft survival in sensitized mice. Transplant Proc 2010;42(6): 2109-2111.
4. Stegall MD, Lafferty KJ, Kam I, Gill RG. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation 1996;61(8): 1272-1274.
5. Niclauss N, Bosco D, Morel P, Giovannoni L, Berney T, Parnaud G. Rapamycin impairs proliferation of transplanted islet b cells. Transplantation 2011;91(7): 714-722.
6. Toso C, Isse K, Demetris AJ, et al. Histologic graft assessment after clinical islet transplantation. Transplantation 2009;88(11): 1286-1293.
7. Menger MD, Wolf B, Höbel R, Schorlemmer HU, Messmer K. Microvascular phenomena during pancreatic islet graft rejection. Langenbecks Arch Chir 1991;376(4): 214-221.
8. Beger C, Menger MD. RS-61443 prevents microvascular rejection of pan- creatic islet xenografts. Transplantation 1997;63(4): 577-582.
9. Moore A, Grimm J, Han B, Santamaria P. Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time. Diabetes 2004;53(6): 1459-1466.
10. Medarova Z, Tsai S, Evgenov N, Santamaria P, Moore A. In vivo imaging of a diabetogenic CD8+ T cell response during type 1 diabetes progression. Magn Reson Med 2008;59(4): 712-720.
11. Medarova Z, Bonner-Weir S, Lipes M, Moore A. Imaging beta-cell death with a near-infrared probe. Diabetes 2005;54(6): 1780-1788.
12. Medarova Z, Castillo G, Dai G, Bolotin E, Bogdanov A, Moore A. Noninvasive magnetic resonance imaging of microvascular changes in type 1 diabetes. Diabetes 2007;56(11): 2677-2682.
13. Bogdanov AA Jr, Weissleder R, Frank HW, et al. A new macromolecule as a contrast agent for MR angiography: preparation, properties, and animal studies. Radiology 1993;187(3): 701-706.
14. Medarova Z, Greiner DL, Ifediba M, et al. Imaging the pancreatic vasculature in diabetes models. Diabetes Metab Res Rev 2011;27(8): 767-772.
15. Bogdanov AA Jr, Mazzanti M, Castillo G, Bolotin E. Protected graft copolymer (PGC) in imaging and therapy: a platform for the delivery of covalently and non-covalently bound drugs. Theranostics 2012;2(6): 553-576.
16. Kim YR, Yudina A, Figueiredo J, et al. Detection of early antiangiogenic effects in human colon adenocarcinoma xenografts: in vivo changes of tumor blood volume in response to experimental VEGFR tyrosine kinase inhibitor. Cancer Res 2005;65(20): 9253-9260.
17. Gupta H, Wilkinson RA, Bogdanov AA Jr, Callahan RJ, Weissleder R. Inflammation: imaging with methoxy poly(ethylene glycol)- poly-L-lysine-DTPA, a long-circulating graft copolymer. Radiology 1995;197(3): 665-669.
18. Wunder A, Tung CH, Müller-Ladner U, Weissleder R, Mahmood U. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 2004;50(8): 2459-2465.
19. Friedman T, Smith RN, Colvin RB, Iacomini J. A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts. Diabetes 1999;48(12): 2340-2348.
20. Alexander AM, Crawford M, Bertera S, et al. Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes. Diabetes 2002;51(2): 356-365.
21. Evgenov NV, Medarova Z, Pratt J, et al. In vivo imaging of immune rejection in transplanted pancreatic islets. Diabetes 2006;55(9): 2419-2428.
22. Narang AS, Mahato RI. Biological and biomaterial approaches for improved islet transplantation. Pharmacol Rev 2006;58(2): 194-243.
23. Triponez F, Oberholzer J, Morel P, et al. Xenogeneic islet re-transplantation in mice triggers an accelerated, species-specific rejection. Immunology 2000;101(4): 548-554.
24. Lobo PI, Spencer C, Simmons WD, et al. Development of anti-human leukocyte antigen class 1 antibodies following allogeneic islet cell transplantation. Transplant Proc 2005;37(8): 3438-3440.
25. Bosi E, Braghi S, Maffi P, et al. Autoantibody response to islet transplantation in type 1 diabetes. Diabetes 2001;50(11): 2464-2471.
26. Huurman VA, Velthuis JH, Hilbrands R, et al. Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation. Am J Transplant 2009;9(2): 382-388.
27. Toso C, Pawlick R, Lacotte S, et al. Detecting rejection after mouse Islet transplantation utilizing islet protein-stimulated ELISPOT. Cell Transplant 2011;20(6): 955-962.
28. Monti P, Scirpoli M, Maffi P, et al. Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells. J Clin Invest 2008;118(5): 1806-1814.
29. Gudemez E, Turegun M, Zins J, Siemionow M. Microvascular permeability following composite tissue transplantation. Ann Plast Surg 1998;41(5): 519-529.
30. Evgenov NV, Medarova Z, Dai G, Bonner- Weir S, Moore A. In vivo imaging of islet transplantation. Nat Med 2006;12(1): 144-148.
31. Medarova Z, Vallabhajosyula P, Tena A, et al. In vivo imaging of autologous islet grafts in the liver and under the kidney capsule in non-human primates. Transplantation 2009;87(11): 1659-1666.
32. Tai JH, Foster P, Rosales A, et al. Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla. Diabetes 2006;55(11): 2931-2938.
33. Nyqvist D, Köhler M, Wahlstedt H, Berggren PO. Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts. Diabetes 2005;54(8): 2287-2293.
34. Brissova M, Fowler M, Wiebe P, et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 2004;53(5): 1318-1325.
35. Vajkoczy P, Olofsson AM, Lehr HA, et al. Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. Am J Pathol 1995;146(6): 1397-1405.